Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis
Chong Wu(Sun Yat-sen University), Limin Zheng(Weifang University of Science and Technology), Jun Cui(Xinjiang Medical University), Jiaqi Ren(Chinese Academy of Sciences), Chun‐Kui Shao(Sun Yat-sen University), Bin Wei(Shanghai University), Shufeng Luo(Central South University), Huiheng Ning(Sun Yat-sen University), Jie Lin, Mingyu Liu(General Hospital of Guangzhou Military Command), Jing Liang(Fujian Medical University), Wen-Chao Wu(Sun Yat-sen University), Xu Jing(Sun Yat-sen University), Minshan Chen(Sun Yat-sen University), Wenjie Zhu(Nanchang University)
Cited by 190
Related Papers
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
|Cell Metabolism|2020|1.7k
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k
Perfluoroalkyl substance pollutants activate the innate immune system through the AIM2 inflammasome
|Nature Communications|2021|231
Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy <i>versus</i> lenvatinib alone for advanced hepatocellular carcinoma
|Therapeutic Advances in Medical Oncology|2021|216